ArticleInternational journal of radiation oncology, biology, physics2020

A Phase 1b Study of Cetuximab and BYL719 (Alpelisib) Concurrent with Intensity Modulated Radiation Therapy in Stage III-IVB Head and Neck Squamous Cell Carcinoma.

Lara A Dunn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.